Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPECIFY: Saxagliptin vs Glimepiride in T2D
NCT02280486Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Nanjing Drum-Tower Hospital. Started Jan 2015; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02280486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280486.